Zurich Insurance Group Ltd. ADR (ZURVY)
Zurich Insurance: Record FY25 And Acquisition Reinforce Upside Potential
Zurich Insurance Group delivered record 2025 profits, with net income and EPS up 17% and 13%, respectively. The P&C division led with a 22% BOP increase, while the Life and Farmers segments posted robust growth, supporting strong operational momentum. A 259% solvency ratio, higher DPS, and disciplined capital deployment reinforce ZURVY's financial flexibility, while operational momentum has yet to be fully reflected in the share price.
Zurich Insurance Earnings Rise on Growth Across Business Lines
The insurer posted a 17% rise in profit for 2025 to $6.80 billion as it delivered record annual earnings.
AXAHY or ZURVY: Which Is the Better Value Stock Right Now?
Investors interested in Insurance - Multi line stocks are likely familiar with Axa Sa (AXAHY) and Zurich Insurance Group Ltd. (ZURVY). But which of these two stocks is more attractive to value investors?
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
Investors interested in Insurance - Multi line stocks are likely familiar with Axa Sa (AXAHY) and Zurich Insurance Group Ltd. (ZURVY). But which of these two stocks offers value investors a better bang for their buck right now?
Zurich Insurance: Solid Results, De-Risked Outlook, And Scope For A Larger Buyback
Zurich Insurance Group's Q3 update shows solid premium growth, especially in Life & Health and Farmers divisions. We now have supportive evidence that ZURVY improved its cost management on lower Nat-cat losses. Zurich's financial strength is highlighted by a 257% Solvency II ratio and potential for higher shareholders' remuneration. Guidance remains intact, and so does our valuation. Buy confirmed.
Zurich Insurance: Income Remains The Most Attractive Feature Of Its Investment Case
Zurich Insurance remains a quality European insurer with strong capitalization and a 5.2% forward dividend yield, but limited upside potential. ZURVY's operational performance is solid, with growth in gross premiums and record profits in core segments, yet bottom-line growth is muted. The company's premium valuation, conservative capital return policy, and modest growth targets justify a 'Hold' rating despite attractive income.
Zurich Insurance: Strong Execution With Positive Farmers Growth Ahead
Zurich Insurance delivered record H1 results, with sector-leading EBIT, ROE, and broad-based profit growth across all divisions, validating our buy thesis. Our investment thesis is supported by rising individual risk aversion and robust capital allocation. With a 10% total return outlook and continued EPS momentum, ZURVY remains a top pick for growth and yield in the insurance sector.
Zurich Insurance Group AG (ZURVY) Q2 2025 Earnings Call Transcript
Zurich Insurance Group AG (OTCQX:ZURVY) Q2 2025 Earnings Conference Call August 7, 2025 7:00 AM ET Company Participants Claudia Cordioli - Group CFO & Member of Executive Committee Mario Greco - Group CEO & Member of Executive Committee Mitchell Todd - Corporate Participant Conference Call Participants Andrew Baker - Goldman Sachs Group, Inc., Research Division Andrew Sinclair - BofA Securities, Research Division Andrew John Crean - Bernstein Autonomous LLP Dominic Alexander O'Mahony - BNP Paribas Exane, Research Division Fahad Usman Changazi - Kepler Cheuvreux, Research Division James Austin Shuck - Citigroup Inc., Research Division Kamran Mark Hossain - JPMorgan Chase & Co, Research Division Michael Igor Huttner - Joh. Berenberg, Gossler & Co. KG, Research Division Vinit Malhotra - Mediobanca—Banca di credito finanziario S.p.A.
Zurich Insurance: Good Operating Performance Seems To Be Priced-In Following Q1 Sales Update
Zurich's recent financial performance has been strong, with earnings growth, profitability, and capital ratios exceeding targets, leading to increased medium-term goals for 2025-27. The company has shown robust growth in P&C and Life segments, with significant improvements in operating earnings and a strong capital position supporting dividend growth. Despite positive trends, Zurich's high valuation, trading at 3.9x book value and 15.6x forward earnings, suggests overvaluation compared to peers like AXA and Allianz.
Zurich Insurance: More Growth Ahead, Buy Confirmed
Zurich Insurance Group's Q1 results showed solid P&C premiums, strong Life business growth, and a higher-than-expected Solvency II ratio of 256%. We forecast a CHF 1 billion share buyback, driven by strong solvency and operating cash flow, complementing a 4.7% dividend yield. With projected EPS growth of 9% and a high RoE, we raised our target price and confirmed our buy rating.
Zurich Insurance: Supportive Fundamentals With EPS Growth And Defensive CHF Yield
Zurich Insurance: Supportive Fundamentals With EPS Growth And Defensive CHF Yield
Zurich Insurance Group AG (ZURVY) Q4 2024 Earnings Call Transcript
Zurich Insurance Group AG (OTCQX:ZURVY) Q4 2024 Results Conference Call February 20, 2025 9:00 AM ET Company Participants Mitchell Todd - Head of Investor Relations Mario Greco - Chief Executive Officer Claudia Cordioli - Chief Financial Officer Conference Call Participants Andrew Sinclair - BofA Global Research Andrew Baker - Goldman Sachs Michael Huttner - Berenberg Andrew Crean - Autonomous Research Kamran Hossain - J.P. Morgan William Hawkins - KBW Will Hardcastle - UBS Dominic O'Mahony - BNP Paribas Exane Vinit Malhotra - Mediobanca Fahad Changazi - Kepler Cheuvreux Marcus Rivaldi - Jefferies Mitchell Todd Good afternoon, everybody, and welcome to Zurich Insurance Group's Full Year 2024 Results Q&A Call.
